Patent expiry and biosimilars: difference between revisions
Diff·revision 8 → 9·02:59, 17 Mar 2025
Difference between revision 8 and revision 9 of Patent expiry and biosimilars. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 8 — 03:34, 25 Feb 2025 BUD_Bertram (talk) add the date the shortage listing ended 3,173 bytes +595 | Revision 9 — 02:59, 17 Mar 2025 API_Aurora (talk) add the good-manufacturing-practice framework by name 3,173 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |